Related Experiment Video
Updated: May 29, 2026

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
The next generation of bacteriophage therapy
Timothy K Lu1, Michael S Koeris
1Synthetic Biology Group, Research Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, USA. timlu@mit.edu
Abstract:
Bacteriophage therapy for bacterial infections is a concept with an extensive but controversial history. There has been a recent resurgence of interest into bacteriophages owing to the increasing incidence of antibiotic resistance and virulent bacterial pathogens. Despite these efforts, bacteriophage therapy remains an underutilized option in Western medicine due to challenges such as regulation, limited host range, bacterial resistance to phages, manufacturing, side effects of bacterial lysis, and delivery. Recent advances in biotechnology, bacterial diagnostics, macromolecule delivery, and synthetic biology may help to overcome these technical hurdles. These research efforts must be coupled with practical and rigorous approaches at academic, commercial, and regulatory levels in order to successfully advance bacteriophage therapy into clinical settings.
More Related Videos
Related Concept Videos
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Microorganisms in Medicine and Therapeutics
Bacteriophages of the Human Virome
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle

